Report : Genomics Market to 2025 - Global Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, and Others), Product & Service (Instruments/Systems, Consumables, and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research, and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, and Others) and Geography
Sequencing Segment is expected to grow the Market for Genomics over the Forecast Period for Technology Segment.
According to The Insight Partners market research study titled ‘Genomics Market to 2025 – Global Analysis and Forecasts by Technology, Product & Services, Application and End User’. The global genomics market is expected to reach US$ 32,995.3 Mn in 2025 from US$ 14,728.6 in 2017. The market is estimated to grow with a CAGR of 10.8% from 2018-2025. The report highlights the trends prevalent in the global genomics market and the factors driving the market along with those that act as deterrents to its growth.
Global genomics market, based on technology was segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. In 2017, sequencing segment held the largest share of the market, by technology. Moreover, the sequencing segment held the largest share of the market owing to its variant libraries, genes, operons, increase the function of proteins, and to test the particular gene. However, the microarray segment is expected to grow at the fastest rate during the coming years.
The market for genomics is expected to grow as growth in investments & funds for genomics, declining cost of sequencing procedures, increasing number of start-up companies, technological advancements in genomics are expected to fuel the market growth during the forecast period. In addition, the technologies of genomics are likely to have a positive impact on the growth of the market in the coming years.
The major players operating in the genomics market include Thermo Fisher Scientific Inc., Illumina Inc., and Eurofins, Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Danaher, and GE Healthcare. For instance, in October 2018, Roche launched the three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumours, complement Roche’s NGS ctDNA kits for oncology research. The developments performed by the companies are helping the market to grow in the coming years.
The report segments the global genomics market as follows:
Global Genomics Market – By Technology
Polymerase Chain Reaction
Nucleic Acid Extraction and Purification
Global Genomics Market – By Product & Services
Global Genomics Market – By Application
Drug Discovery and Development
Agriculture & Animal Research
Global Genomics Market – By End User
Hospitals & Clinics
Biotechnology & Pharmaceutical Companies
Global Genomics Market – By Geography
Asia Pacific (APAC)
Middle East & Africa (MEA)
South & Central America (SCAM)
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org